Share on StockTwits
 

Imperva (NASDAQ:IMPV) set a new 52-week high during mid-day trading on Friday, ARN reports. The stock traded as high as $60.44 and last traded at $59.35, with a volume of 603,521 shares. The stock had previously closed at $55.30.

IMPV has been the subject of a number of recent research reports. Analysts at Wedbush raised their price target on shares of Imperva from $47.00 to $51.00 in a research note to investors on Friday. Separately, analysts at Pacific Crest raised their price target on shares of Imperva from $57.00 to $62.00 in a research note to investors on Friday. Finally, analysts at BMO Capital Markets raised their price target on shares of Imperva from $52.00 to $57.00 in a research note to investors on Friday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $55.44.

Imperva has a one year low of $34.83 and a one year high of $57.60. The stock has a 50-day moving average of $51.97 and a 200-day moving average of $46.21. The company’s market cap is $1.452 billion.

Imperva (NASDAQ:IMPV) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.12 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.11 by $0.01. The company had revenue of $42.70 million for the quarter, compared to the consensus estimate of $41.63 million. During the same quarter in the prior year, the company posted $0.06 earnings per share. The company’s quarterly revenue was up 34.3% on a year-over-year basis. On average, analysts predict that Imperva will post $0.10 earnings per share for the current fiscal year.

Imperva, Inc is a United States-based Company that develops data security solutions for business data in the data center.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.